TY  - GEN
AU  - Sarna,G
AU  - Pertcheck,M
AU  - Figlin,R
AU  - Ardalan,B
TI  - Phase I study of recombinant beta ser 17 interferon in the treatment of cancer
SN  - 0361-5960
PY  - 1987///0130
KW  - 2',5'-Oligoadenylate Synthetase
KW  - analysis
KW  - Adult
KW  - Aged
KW  - Antibodies
KW  - Chemical and Drug Induced Liver Injury
KW  - Drug Administration Schedule
KW  - Drug Evaluation
KW  - Female
KW  - Hematologic Diseases
KW  - chemically induced
KW  - Humans
KW  - Interferon Type I
KW  - adverse effects
KW  - Interferon beta-1a
KW  - Interferon beta-1b
KW  - Interferon-beta
KW  - Kidney Diseases
KW  - Kinetics
KW  - Lymphocytes
KW  - enzymology
KW  - Male
KW  - Middle Aged
KW  - Nausea
KW  - Neoplasms
KW  - blood
KW  - Recombinant Proteins
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
ER  -